SMAD3 and breast carcinoma: A study on the relationship between MMP9 and the TGF signaling pathway in breast cancer showed that overexpression of MMP9 in breast cancer cells not only significantly up-regulated the expression of SMAD2, SMAD3 and SMAD4, but also enhanced the phosphorylation of SMAD2 (116).